Literature DB >> 8530403

Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.

S T Olson1, P E Bock, J Kvassman, J D Shore, D A Lawrence, D Ginsburg, I Björk.   

Abstract

The contribution of a covalent bond to the stability of complexes of serine proteinases with inhibitors of the serpin family was evaluated by comparing the affinities of beta-trypsin and the catalytic serine-modified derivative, beta-anhydrotrypsin, for several serpin and non-serpin (Kunitz) inhibitors. Kinetic analyses showed that anhydrotrypsin had little or no ability to compete with trypsin for binding to alpha 1-proteinase inhibitor (alpha 1PI), plasminogen activator inhibitor 1 (PAI-1), antithrombin (AT), or AT-heparin complex when present at up to a 100-fold molar excess over trypsin. By contrast, equimolar levels of anhydrotrypsin blocked trypsin binding to non-serpin inhibitors. Equilibrium binding studies of inhibitor-enzyme interactions monitored by inhibitor displacement of the fluorescence probe, p-aminobenzamidine, from the enzyme active site, confirmed that the binding of serpins to anhydrotrypsin was undetectable in the case of alpha 1PI or AT (KI > 10(-5) M), of low affinity in the case of AT-heparin complex (KI 7-9 x 10(-6) M), and of moderate affinity in the case of PAI-1 (KI 2 x 10(-7) M). This contrasted with the stoichiometric high affinity binding of the serpins to trypsin as well as of the non-serpin inhibitors to both trypsin and anhydrotrypsin. Maximal KI values for serpin-trypsin interactions of 1 to 8 x 10(-11) M, obtained from kinetic analyses of association and dissociation rate constants, indicated that the affinity of serpins for trypsin was minimally 4 to 6 orders of magnitude greater than that of anhydrotrypsin. Anhydrotrypsin, unlike trypsin, failed to induce the characteristic fluorescence changes in a P9 Ser-->Cys PAI-1 variant labeled with a nitrobenzofuran fluorescent probe (NBD) which were shown previously to report the serpin conformational change associated with active enzyme binding. These results demonstrate that a covalent interaction involving the proteinase catalytic serine contributes a major fraction of the binding energy to serpin-trypsin interactions and is essential for inducing the serpin conformational change involved in the trapping of enzyme in stable complexes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530403     DOI: 10.1074/jbc.270.50.30007

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Systemic enzyme therapy in oncology: effect and mode of action.

Authors:  J Leipner; R Saller
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

2.  Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.

Authors:  Steven T Olson; Richard Swanson; Maurice Petitou
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

3.  Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.

Authors:  I Björk; K Nordling; E Raub-Segall; U Hellman; S T Olson
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

4.  Major proteinase movement upon stable serpin-proteinase complex formation.

Authors:  E Stratikos; P G Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Pepsin-inhibitory activity of the uterine serpins.

Authors:  N Mathialagan; T R Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 6.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Kinetic intermediates en route to the final serpin-protease complex: studies of complexes of α1-protease inhibitor with trypsin.

Authors:  Ashoka A Maddur; Richard Swanson; Gonzalo Izaguirre; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

8.  Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.

Authors:  Alireza R Rezaie; Chandrashekhara Manithody; Likui Yang
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

9.  Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases.

Authors:  Likui Yang; Shabir H Qureshi; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

10.  Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.

Authors:  Gonzalo Izaguirre; Alireza R Rezaie; Steven T Olson
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.